These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 2482642)
1. [O-specific L-hapten in the composition of Shigella sonnei]. Egorova TP; Sazykina SIu; Fedosova VG; Lebenson VI Zh Mikrobiol Epidemiol Immunobiol; 1989 Nov; (11):8-13. PubMed ID: 2482642 [TBL] [Abstract][Full Text] [Related]
2. [The immunogenic and serological properties of the O-specific polysaccharide (L-hapten) in Shigella]. Levenson VI; Belkin ZP; Egorova TP; Liubinskaia MM; Sazykina SIu Zh Mikrobiol Epidemiol Immunobiol; 1991 Jul; (7):25-9. PubMed ID: 1719715 [TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of Shigella sonnei phase I O-antigen. Kułakowska M; Romanowska E Arch Immunol Ther Exp (Warsz); 1981; 29(5):573-80. PubMed ID: 6181756 [TBL] [Abstract][Full Text] [Related]
4. Polysaccharide nature of O antigen in protective ribosomal preparations from Shigella: experimental evidence and implications for the ribosomal vaccine concept. Levenson VI; Egorova TP Res Microbiol; 1990; 141(6):707-20. PubMed ID: 1704638 [TBL] [Abstract][Full Text] [Related]
5. Unusual lipopolysaccharide antigens of a Salmonella typhi oral vaccine strain expressing the Shigella sonnei form I antigen. Seid RC; Kopecko DJ; Sadoff JC; Schneider H; Baron LS; Formal SB J Biol Chem; 1984 Jul; 259(14):9028-34. PubMed ID: 6378905 [TBL] [Abstract][Full Text] [Related]
8. [The molecular heterogeneity of Shigella sonnei lipopolysaccharide based on polyacrylamide gel electrophoretic data]. Nartikova VF; Levenson VI Zh Mikrobiol Epidemiol Immunobiol; 1990 Jul; (7):10-4. PubMed ID: 2251881 [TBL] [Abstract][Full Text] [Related]
9. [Specificity of the protective action of a ribosomal Shigella vaccine and the absence of activity in the ribosomes from R mutants]. Levenson VI; Rukhadze EZ; Belkin ZP; Essaulova ME Zh Mikrobiol Epidemiol Immunobiol; 1988 Oct; (10):55-9. PubMed ID: 2464261 [TBL] [Abstract][Full Text] [Related]
11. [Immunoelectrophoretic analysis of the antigenic structure of Sh. sonnei]. Nguen Zuĭ Kho ; Belaia IuA Zh Mikrobiol Epidemiol Immunobiol; 1978 Jun; (6):55-61. PubMed ID: 79280 [TBL] [Abstract][Full Text] [Related]
12. Stable expression of Shigella sonnei form I O-polysaccharide genes recombineered into the chromosome of live Salmonella oral vaccine vector Ty21a. Dharmasena MN; Hanisch BW; Wai TT; Kopecko DJ Int J Med Microbiol; 2013 Apr; 303(3):105-13. PubMed ID: 23474241 [TBL] [Abstract][Full Text] [Related]
13. [Immunochemistry of Shigella (a review of the most important results). III. O-antigens of Shigella sonnei and the thermolabile antigen that moves to the anode]. Seltmann G Zh Mikrobiol Epidemiol Immunobiol; 1977 Aug; (8):3-6. PubMed ID: 335741 [No Abstract] [Full Text] [Related]
14. [Biological properties of a ribosomal vaccine from S. sonnei obtained by polyethylene glycol fractionation]. Levenson VI; Rukhadze EZ; Fedosova VG; Dzhikidze EK; Stasilevich ZK Zh Mikrobiol Epidemiol Immunobiol; 1984 Nov; (11):77-81. PubMed ID: 6395593 [TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and characterization of the genetic determinants that express the complete Shigella serotype D (Shigella sonnei) lipopolysaccharide in heterologous live attenuated vaccine strains. Viret JF; Cryz SJ; Lang AB; Favre D Mol Microbiol; 1993 Jan; 7(2):239-52. PubMed ID: 7680409 [TBL] [Abstract][Full Text] [Related]
16. Shigella sonnei infection of zebrafish reveals that O-antigen mediates neutrophil tolerance and dysentery incidence. Torraca V; Kaforou M; Watson J; Duggan GM; Guerrero-Gutierrez H; Krokowski S; Hollinshead M; Clarke TB; Mostowy RJ; Tomlinson GS; Sancho-Shimizu V; Clements A; Mostowy S PLoS Pathog; 2019 Dec; 15(12):e1008006. PubMed ID: 31830135 [TBL] [Abstract][Full Text] [Related]
18. [A study of pancrealysates of Sh. flexneri 2a and Sh. sonnei fractionated by filtration through Sephadex G-200 and ultracentrifugation]. Kaverina KG; Shuvaeva LP; Zhvanetskaia MI; Rostovtseva NA; Kreinin LS Zh Mikrobiol Epidemiol Immunobiol; 1976 Jul; (7):51-6. PubMed ID: 795248 [TBL] [Abstract][Full Text] [Related]
19. Immunochemical characteristics of Shigella sonnei and serotype 6 Shigella flexneri lipopolysaccharides and enterobacterial common antigen. Romanowska E; Katzenellenbogen E; Lugowski C; Gamian A; Bogulska M Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):249-54. PubMed ID: 86336 [TBL] [Abstract][Full Text] [Related]
20. Development of Shigella sonnei live oral vaccines based on defined rfbInaba deletion mutants of Vibrio cholerae expressing the Shigella serotype D O polysaccharide. Favre D; Cryz SJ; Viret JF Infect Immun; 1996 Feb; 64(2):576-84. PubMed ID: 8550210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]